Esther Groettrup‐Wolfers

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study

Sukhbir S. Singh, James A. Simon, Kristina Gemzell‐Danielsson et al. · Fertility and Sterility · 2018 · 36 citations · Full text

Medicine, Gynecology, Pharmacotherapy +15

Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2

Kristina Gemzell‐Danielsson, Oskari Heikinheimo, János Zatik et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2020 · 20 citations

Medicine, Gynecology, Pharmacotherapy +9

Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis

Jan Hilpert, Esther Groettrup‐Wolfers, Hristiyan Kosturski et al. · Drugs in R&D · 2023 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy, safety and tolerability of the <scp>CCR</scp>1 antagonist <scp>BAY</scp> 86‐5047 for the treatment of endometriosis‐associated pelvic pain: a randomized controlled trial

Dietmar Trummer, Anja Walzer, Esther Groettrup‐Wolfers et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2017 · 13 citations · Full text

Medicine, Gynecology, Pharmacology +14

Results of the asteroid (assess safety and efficacy of vilaprisan in patients with uterine fibroids) 1 study: a phase 2, placebo-controlled dose finding study

Xiaowei Ren, Esther Groettrup‐Wolfers, Kathrin Petersdorf et al. · Fertility and Sterility · 2016 · 11 citations

Medicine, Gynecology, Pharmacotherapy +7